Trends in lung cancer incidence and mortality in Croatia, 1988 to 2008

Por Janković, Mateja, Samaržija, Miroslav, Jakopović, Marko, Kuliš, Tomislav, Znaor, Ariana
Publicado em 2012

Giant, Dissecting, High-Pressure Pulmonary Artery Aneurysm: Case Report of a 1-Year Natural Course

Por Smalcelj, Anton, Brida, Vojtjeh, Samarzija, Miroslav, Matana, Ante, Margetic, Eduard, Drinkovic, Niksa
Publicado em 2005

Synchronous Adie's syndrome and type 1 antineuronal nuclear antibody (anti-Hu)-related paraneoplastic neurological syndromes as predictors of complete response in limited-stage sma...

Por Sreter, Katherina Bernadette, Barisic, Blazenka, Barisic Kutija, Marija, Kukulj, Suzana, Samarzija, Miroslav
Publicado no Mol Clin Oncol (2017)

Anemia, hypoalbuminemia, and elevated troponin levels as risk factors for respiratory failure in patients with severe exacerbations of chronic obstructive pulmonary disease requiri...

Por Pavliša, Gordana, Labor, Marina, Puretić, Hrvoje, Hećimović, Ana, Jakopović, Marko, Samaržija, Miroslav
Publicado no Croat Med J (2017)

Cancer-related inflammation as predicting tool for treatment outcome in locally advanced and metastatic non-small cell lung cancer

Por Badovinac, Sonja, Korsic, Marta, Mursic, Davorka, Samarzija, Miroslav, Cucevic, Branka, Roglic, Mihovil, Jakopovic, Marko
Publicado no J Thorac Dis (2016)

P29. Oral topotecan in small cell lung cancer: treatment related side effects

Por Popovic, Filip, Samarzija, Miroslav, Kukulj, Suzana, Redzepi, Gzim, Roglic, Mihovil, Mursic, Davorka, Cucevic, Branka, Plestina, Sanja, Jakopovic, Marko
Publicado no Transl Lung Cancer Res (2014)

Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia

Por Brcic, Luka, Jakopovic, Marko, Misic, Marija, Seiwerth, Fran, Kern, Izidor, Smojver-Jezek, Silvana, Quehenberger, Franz, Samarzija, Miroslav, Seiwerth, Sven
Publicado no Diagn Pathol (2016)

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio help identify patients with lung cancer, but do not differentiate between lung cancer subtypes

Por Nikolić, Igor, Kukulj, Suzana, Samaržija, Miroslav, Jeleč, Vjekoslav, Žarak, Marko, Orehovec, Biserka, Taradi, Ida, Romić, Dominik, Kolak, Toni, Patrlj, Leonardo
Publicado no Croat Med J (2016)

P11. Efficacy and safety of erlotinib in advanced squamous cell lung cancer

Por Jakopovic, Marko, Cucevic, Branka, Plestina, Sanja, Kukulj, Suzana, Roglic, Mihovil, Smojver-Jezek, Silvana, Roglic, Mihovil, Korsic, Marta, Redzepi, Gzim, Samarzija, Miroslav
Publicado no Transl Lung Cancer Res (2014)

Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research – a consensus document from six scientific societies

Por Rossi, Andrea, Butorac-Petanjek, Bojana, Chilosi, Marco, Cosío, Borja G, Flezar, Matjaz, Koulouris, Nikolaos, Marin, José, Miculinic, Neven, Polese, Guido, Samaržija, Miroslav, Skrgat, Sabina, Vassilakopoulos, Theodoros, Vukić-Dugac, Andrea, Zakynthinos, Spyridon, Miravitlles, Marc
Publicado no Int J Chron Obstruct Pulmon Dis (2017)

A pilot study—is there a role for mitoxantrone pleurodesis in the management of pleural effusion due to lung cancer?

Por Sreter, Katherina-Bernadette, Jakopovic, Marko, Janevski, Zoran, Samarzija, Miroslav, Zarogoulidis, Paul, Kioumis, Ioannis, Mparmpetakis, Nikolaos, Pataka, Athanasia, Zarogoulidis, Konstantinos, Tsiouda, Theodora, Kosmidis, Christoforos, Mpaka, Sofia, Huang, Haidong, Hohenforst-Schmidt, Wolfgang, Charalampidis, Charalampos, Machairiotis, Nikolaos, Zaric, Bojan, Milovancev, Aleksandar
Publicado no Ann Transl Med (2016)